[1]梁淑芳,黄国开,聂姝常,等.薯蓣皂苷元对非酒精性脂肪性肝病小鼠脂质代谢的影响[J].西部中医药,2025,38(02):6-9.[doi:10.12174/j.issn.2096-9600.2025.02.02]
　LIANG Shufang,HUANG Guokai,NIE Shuchang,et al.Impacts of Diosgenin on Lipid Metabolism in Non-alcoholic Fatty Liver Disease Mice[J].Western Journal of Traditional Chinese Medicine,2025,38(02):6-9.[doi:10.12174/j.issn.2096-9600.2025.02.02]
点击复制

薯蓣皂苷元对非酒精性脂肪性肝病小鼠脂质代谢的影响()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年02期
页码:
6-9
栏目:
基础研究
出版日期:
2025-02-15

文章信息/Info

Title:
Impacts of Diosgenin on Lipid Metabolism in Non-alcoholic Fatty Liver Disease Mice
作者:
梁淑芳1, 黄国开1, 聂姝常1, 程彬彬2, 刘群1
1.海军军医大学第一附属医院，上海 200433
2.海军军医大学，上海 200433
Author(s):
LIANG Shufang1, HUANG Guokai1, NIE Shuchang1, CHENG Binbin2, LIU Qun1
1.Changhai Hospital, Shanghai 200433, China
2.Naval Medical University, Shanghai 200433, China
关键词:
脂肪性肝病; 非酒精性; 脂质代谢; 薯蓣皂苷元; 小鼠
Keywords:
fatty liver disease;  non-alcoholic; lipid metabolism; diosgenin; mice
分类号:
R256.49
DOI:
10.12174/j.issn.2096-9600.2025.02.02
文献标志码:
A
摘要:
目的探讨薯蓣皂苷元对高脂饮食诱导的非酒精性脂肪性肝病（non-alcoholic fatty liver disease，NAFLD）模型小鼠肝组织脂质沉积与血清甘油三酯（triglyceride，TG）、总胆固醇（total cholesterol，TC）水平的影响。 方法将40只雄性ICR小鼠按随机数字表法分为对照组、模型组、薯蓣皂苷元高、低剂量组及非诺贝特组，每组8只。对照组予普通饲料；模型组予45%脂肪供能的高脂饲料；薯蓣皂苷元高、低剂量组分别予薯蓣皂苷元混合饲料，即每千克高脂饲料中分别含薯蓣皂苷元10 g和5 g；非诺贝特组予非诺贝特混合饲料，即每千克高脂饲料中含非诺贝特200 mg，连续干预16周。应用苏木精-伊红染色法（hematoxylin-eosin staining，HE）观察肝组织病理形态学变化；油红O染色法观察肝脏脂肪沉积情况；测定血清TG和TC表达水平。 结果HE染色结果显示：模型组小鼠脂肪变性程度较对照组严重，薯蓣皂苷元高、低剂量组和非诺贝特组肝细胞胞浆内空泡样变减轻。油红O染色结果显示：模型组小鼠肝组织脂肪含量高于对照组，而薯蓣皂苷元高、低剂量组及非诺贝特组肝细胞脂肪含量降低。与对照组比较，模型组小鼠血清TG和TC水平均升高（P＜0.01）；与模型组比较，薯蓣皂苷元高、低剂量组和非诺贝特组TG和TC水平均降低（P＜0.01）；与非诺贝特组比较，薯蓣皂苷元高、低剂量组TG和TC表达水平差异无统计学意义（P＞0.05）。 结论薯蓣皂苷元能够降低高脂饮食诱导的NAFLD模型小鼠肝细胞脂肪变性程度和脂肪含量及血清TG和TC表达水平。
Abstract:
ObjectiveTo survey the influence of diosgenin on the levels of TG and TC, lipid deposition in liver tissue of the mice with non-alcoholic fatty liver disease (NAFLD) induced by high fat diet. MethodsForty male ICR mice were allocated to the control group, the model group, high and low dosage groups of diosgenin, and fenofibrate group with eight in each group. The control group was fed with common fodder, the model group was given high-fat feed with 45% fat for energy; diosgenin mixed forage, that is, each kilogram of high-fat feed contained 10 g and 5 g of diosgenin respectively, was administered to high and low dosage groups of diosgenin respectively; fenofibrate-mixed fodder, that is, each kilogram of high-fat feed included fenofibrate 200 mg, was given to fenofibrate group, all the groups accepted 16 consecutive weeks of the treatment. HE staining was applied to observe the pathomorphology of liver tissue; oil red O (ORO) staining was utilized to observe the fat deposition in the liver; to detect the expressions of serum TG and TC. ResultsHE staining results displayed that the degrees of adipose degeneration of the model group were severer than these of the control group, intracytoplasmic vacuola-tion was reduced in high and low dosage groups of diosgenin, and fenofibrate group. ORO staining showed that: fat contents of the liver tissue of the model group were higher than these of the control group, while fat contents in hepatic cell were lowered in high and low dosage groups of diosgenin, and fenofibrate group. Compared with the control group, the levels of TG and TC were elevated in the model group (P<0.01); Compared with the model group, the levels of TG and TC were lowered in high and low dosage groups of diosgenin, and fenofibrate group (P<0.01); no statistical difference was found in the levels of TG and TC when high and low dosage groups of diosgenin were compared with fenofibrate group (P>0.05). ConclusionDiosgenin could reduce adipose degenera-tion in hepatic cells and fat contents in NAFLD mice models induced by high-fat food, and the expressions of TG and TC.

相似文献/References:

[1]王磊.泽泻饮合京三棱丸治疗非酒精性脂肪肝34例[J].西部中医药,2013,26(09):64.
　WANG Lei.ZeXie Drink and Jing SanLengWan in Treating 34 Cases of Non Alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(02):64.
[2]王晋阳,杨少军△,井小会.中医药化浊降脂法治疗非酒精性脂肪肝的研究进展*[J].西部中医药,2015,28(02):132.
[3]陈芳玉,张杰,毛莲香,等.疏肝健脾化痰汤治疗非酒精性脂肪性肝炎50例[J].西部中医药,2015,28(06):94.[doi:2015/6/16 0:00:00]
[4]张玉香,王一强,姜德民,等.清肝祛湿活血方对非酒精性脂肪肝大鼠肿瘤坏死因子α及肝脏组织的影响[J].西部中医药,2018,31(08):13.
　ZHANG Yuxiang,WANG Yiqiang,JIANG Demin,et al.Effects of Liver-clearing Dampness-removing Blood Circulation-promoting Prescription on Liver Tissue and TNF-α of the Rats with Non-alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(02):13.
[5]江明洁,贺劲松△.“三因制宜”理论辨治非酒精性脂肪性肝病[J].西部中医药,2018,31(10):22.
　JIANG Mingjie,HE Jinsong.Differentiating and Treating Non-alcoholic Fatty Liver Disease by the Theory of “Treatment Individualized to Patient, Season and Locality”[J].Western Journal of Traditional Chinese Medicine,2018,31(02):22.
[6]陶庆,蓝健姿,曹建红,等.东方肝康口服液治疗非酒精性脂肪性肝病疗效观察[J].西部中医药,2019,32(07):1.
　TAO Qing,LAN Jianzi,CAO Jianhong,et al.Clinical Observation on DongFang GanKang Oral Liquid in the Treatment for Nonalcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2019,32(02):1.
[7]姜慧,李军祥,谭祥,等.基于网络药理学和分子对接探讨健脾疏肝方治疗非酒精性脂肪性肝病的作用机制[J].西部中医药,2024,37(02):83.[doi:10.12174/j.issn.2096-9600.2024.02.17]
　JIANG Hui,LI Junxiang,TAN Xiang,et al.The Mechanism of Invigorating-spleen Soothing-liver Prescription in the Treatment of Non-alcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2024,37(02):83.[doi:10.12174/j.issn.2096-9600.2024.02.17]

备注/Memo

备注/Memo:
梁淑芳（1990—），女，硕士学位，主治医师。研究方向：肝病的中西医结合防治。国家自然科学基金面上项目（81774077）；国家自然科学基金青年基金（82405513）；海军军医大学第一附属医院基础研究专项（2023QD21）；海军军医大学第一附属医院青年启动基金项目（2019QNA06）。
更新日期/Last Update: 2025-02-15